Seeking Alpha

More on Qiagen (QGEN): Q4 beats across the board, led by 4% net sales growth in its Molecular...

More on Qiagen (QGEN): Q4 beats across the board, led by 4% net sales growth in its Molecular Diagnostics and Applied Testing units. Growth was strong across all geographic regions; Americas +46%, Europe +9%, Asia-Pacific & Japan +19%. The company guides FY13 earnings higher, now expecting an EPS of $1.16 - $1.18 - versus the consensus of $1.15 - and revenues to grow about 5% - 6%.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)